In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103

Spriano, FilippoTarantelli, ChiaraArribas, Alberto J.Gaudio, EugenioCascione, LucianoAresu, LucaRinaldi, AndreaZucca, EmanueleRossi, DavideStathis, AnastasiosMurone, MaximilienRadtke, FreddyLehal, RajwinderBertoni, Francesco2023-01-022023-01-022023-01-022022-12-0910.1111/bjh.18576https://infoscience.epfl.ch/handle/20.500.14299/193584WOS:000895800300001Hematologyb-cell lymphomaactivationexpressionsurvivalleukemiatumorIn vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103text::journal::journal article::research article